Selective loss of synaptic proteins in Alzheimer's disease: Evidence for an increased severity with APOE ε4

Neurochemistry International

Volumn 49, Issue 7, 2006, Pages 631-639

  Tannenberg, Rudi K ^a   Scott, Heather L ^a   Tannenberg, Anthony E G ^b   Dodd, Peter R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QML Pathology   (Australia)

Author keywords

Excitatory; Excitotoxicity; Inhibitory; Neurodegeneration; Postsynaptic; Presynaptic

Indexed keywords

APOLIPOPROTEIN E4; COMPLEXIN I; COMPLEXIN II; DYNAMIN I; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; PROTEIN; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCITOTOXICITY; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNAPSE; TEMPORAL CORTEX;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BRAIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CADHERINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; DYNAMIN I; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TESTING; HUMANS; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PRESYNAPTIC TERMINALS; SYNAPTIC MEMBRANES; SYNAPTOPHYSIN;

EID: 33750016561     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.05.004     Document Type: Article

References (57)

1. Bahr B.A., Abai B., Gall C.M., Vanderklish P.W., Hoffman K.B., and Lynch G. Induction of beta-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp. Neurol. 129 (1994) 81-94
2. Benson D.L., and Tanaka H. N-cadherin redistribution during synaptogenesis in hippocampal neurons. J. Neurosci. 18 (1998) 6892-6904
3. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berlin) 82 (1991) 239-259
4. Buttini M., Akeefe H., Lin C., Mahley R.W., Pitas R.E., Wyss-Coray T., and Mucke L. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 97 (2000) 207-210
5. Cambon K., Davies H.A., and Stewart M.G. Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice. Neuroscience 97 (2000) 685-692
6. Cammarota M., Bevilaqua L.R., Viola H., Kerr D.S., Reichmann B., Teixeira V., Bulla M., Izquierdo I., and Medina J.H. Participation of CaMKII in neuronal plasticity and memory formation. Cell. Mol. Neurobiol. 22 (2002) 259-267
7. Colman D.R. Neurites, synapses, and cadherins reconciled. Mol. Cell. Neurosci. 10 (1997) 1-6
8. Davidsson P., and Blennow K. Neurochemical dissection of synaptic pathology in Alzheimer's disease. Int. Psychogeriatr. 10 (1998) 11-23
9. Dodd P.R., Hardy J.A., Baig E.B., Kidd A.M., Bird E.D., Watson W.E., and Johnston G.A. Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain. Neurochem. Pathol. 4 (1986) 177-198
10. Fox K. Synaptic plasticity: the subcellular location of CaMKII controls plasticity. Curr. Biol. 13 (2003) R143-R145
11. Halliday G., Ng T., Rodriguez M., Harding A., Blumbergs P., Evans W., Fabian V., Fryer J., Gonzales M., Harper C., Kalnins R., Masters C.L., McLean C., Milder D.G., Pamphlett R., Scott G., Tannenberg A., and Kril J. Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria. Acta Neuropathol. (Berlin) 104 (2002) 72-78
12. Hamos J.E., DeGennaro L.J., and Drachman D.A. Synaptic loss in Alzheimer's disease and other dementias. Neurology 39 (1989) 355-361
13. Harigaya Y., Shoji M., Shirao T., and Hirai S. Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. J. Neurosci. Res. 43 (1996) 87-92
14. Harrison P.J., and Eastwood S.L. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352 (1998) 1669-1673
15. Hatanpaa K., Isaacs K.R., Shirao T., Brady D.R., and Rapoport S.I. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58 (1999) 637-643
16. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid. Res. 31 (1990) 545-548
17. Honer W.G., Dickson D.W., Gleeson J., and Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging 13 (1992) 375-382
18. 2+/calmodulin-dependent protein kinase II. Biochem. J. 364 (2002) 593-611
19. Itakura M., Misawa H., Sekiguchi M., Takahashi S., and Takahashi M. Transfection analysis of functional roles of complexins I and II in the exocytosis of two different types of secretory vesicles. Biochem. Biophys. Res. Commun. 265 (1999) 691-696
20. Ji Y., Gong Y., Gan W., Beach T., Holtzman D.M., and Wisniewski T. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122 (2003) 305-315
21. Johnston P.A., and Sudhof T.C. The multisubunit structure of synaptophysin. Relationship between disulfide bonding and homo-oligomerization. J. Biol. Chem. 265 (1990) 8869-8873
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
23. Lassmann H., Weiler R., Fischer P., Bancher C., Jellinger K., Floor E., Danielczyk W., Seitelberger F., and Winkler H. Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience 46 (1992) 1-8
24. Liu J.P., Zhang Q.X., Baldwin G., and Robinson P.J. Calcium binds dynamin I and inhibits its GTPase activity. J. Neurochem. 66 (1996) 2074-2081
25. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
26. Masliah E., Terry R.D., Alford M., and DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J. Histochem. Cytochem. 38 (1990) 837-844
27. Masliah E., Terry R.D., DeTeresa R.M., and Hansen L.A. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci. Lett. 103 (1989) 234-239
28. Mattson M.P. Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease. Trends Neurosci. 20 (1997) 373-375
29. Minger S.L., Honer W.G., Esiri M.M., McDonald B., Keene J., Nicoll J.A., Carter J., Hope T., and Francis P.T. Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 929-936
30. Mukaetova-Ladinska E.B., Garcia-Siera F., Hurt J., Gertz H.J., Xuereb J.H., Hills R., Brayne C., Huppert F.A., Paykel E.S., McGee M., Jakes R., Honer W.G., Harrington C.R., and Wischik C.M. Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am. J. Pathol. 157 (2000) 623-636
31. Mukaetova-Ladinska E.B., Harrington C.R., Roth M., and Wischik C.M. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Am. J. Pathol. 143 (1993) 565-578
32. Mukaetova-Ladinska E.B., Harrington C.R., Roth M., and Wischik C.M. Alterations in tau protein metabolism during normal aging. Dementia 7 (1996) 95-103
33. Mukaetova-Ladinska E.B., Harrington C.R., Roth M., and Wischik C.M. Presence of the apolipoprotein E type epsilon 4 allele is not associated with neurofibrillary pathology or biochemical changes to tau protein. Dement. Geriatr. Cogn. Disord. 8 (1997) 288-295
34. Ono S., Baux G., Sekiguchi M., Fossier P., Morel N.F., Nihonmatsu I., Hirata K., Awaji T., Takahashi S., and Takahashi M. Regulatory roles of complexins in neurotransmitter release from mature presynaptic nerve terminals. Eur. J. Neurosci. 10 (1998) 2143-2152
35. Parker Jr. W.D., Filley C.M., and Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40 (1990) 1302-1303
36. Parker Jr. W.D., and Parks J.K. Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization. Neurology 45 (1995) 482-486
37. Pirttila T., Soininen H., Heinonen O., Lehtimaki T., Bogdanovic N., Paljarvi L., Kosunen O., Winblad B., Riekkinen Sr. P., Wisniewski H.M., and Mehta P.D. Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls. Brain Res. 722 (1996) 71-77
38. Qiu Z., Crutcher K.A., Hyman B.T., and Rebeck G.W. ApoE isoforms affect neuronal N-methyl-d-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 122 (2003) 291-303
39. Rebeck G.W., Kindy M., and LaDu M.J. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. J. Alzheimers Dis. 4 (2002) 145-154
40. Reddy P.H., Mani G., Park B.S., Jacques J., Murdoch G., Whetsell Jr. W., Kaye J., and Manczak M. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J. Alzheimers Dis. 7 (2005) 103-117 discussion 173-180
41. Robinson P.J., Liu J.P., Powell K.A., Fykse E.M., and Sudhof T.C. Phosphorylation of dynamin I and synaptic-vesicle recycling. Trends Neurosci. 17 (1994) 348-353
42. Rubinsztein D.C. The genetics of Alzheimer's disease. Prog. Neurobiol. 52 (1997) 447-454
43. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning. A Laboratory Manual (1989), Cold Spring Harbor Laboratory Press
44. Scheff S.W., DeKosky S.T., and Price D.A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol. Aging 11 (1990) 29-37
45. Schlaf G., Salje C., Poethke R., Felgenhauer K., and Mader M. A novel enzyme-linked immunosorbent assay for determination of synaptophysin as compared with other quantification procedures. J. Neuroimmunol. 67 (1996) 59-65
46. Shapiro L., and Colman D.R. Structural biology of cadherins in the nervous system. Curr. Opin. Neurobiol. 8 (1998) 593-599
47. Shapiro L., and Colman D.R. The diversity of cadherins and implications for a synaptic adhesive code in the CNS. Neuron 23 (1999) 427-430
48. Simonian N.A., Elvhage T., Czernik A.J., Greengard P., and Hyman B.T. Calcium/calmodulin-dependent protein kinase II immunostaining is preserved in Alzheimer's disease hippocampal neurons. Brain Res. 657 (1994) 294-299
49. Simonian N.A., and Hyman B.T. Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J. Neuropathol. Exp. Neurol. 53 (1994) 508-512
50. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett Jr. J.P., Davis R.E., and Parker Jr. W.D. Cybrids in Alzheimer's disease: a cellular model of the disease?. Neurology 49 (1997) 918-925
51. Tanaka H., Shan W., Phillips G.R., Arndt K., Bozdagi O., Shapiro L., Huntley G.W., Benson D.L., and Colman D.R. Molecular modification of N-cadherin in response to synaptic activity. Neuron 25 (2000) 93-107
52. Tang L., Hung C.P., and Schuman E.M. A role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiation. Neuron 20 (1998) 1165-1175
53. Teter B. ApoE-dependent plasticity in Alzheimer's disease. J. Mol. Neurosci. 23 (2004) 167-179
54. Wiedenmann B., and Franke W.W. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41 (1985) 1017-1028
55. Yamada M., Saisu H., Ishizuka T., Takahashi H., and Abe T. Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: localization at the distinct central nervous system regions and synaptic types. Neuroscience 93 (1999) 7-18
56. Yao P.J., Zhu M., Pyun E.I., Brooks A.I., Therianos S., Meyers V.E., and Coleman P.D. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol. Dis. 12 (2003) 97-109
57. Ziff E.B. Enlightening the postsynaptic density. Neuron 19 (1997) 1163-1174